Broadtree Partners completed the acquisition of Joint Research and Development.

Broadtree Partners, a middle-market private equity firm, completed the acquisition of Joint Research and Development, a provider of test and evaluation services, total life-cycle acquisition support, medical and public health preparedness, and science and technology research and development. Financial terms were not disclosed. "We're extremely excited to add JRAD to our GovCon platform – JRAD has a unique culture of customer and mission-focused performance and remarkably talented people supporting critical national security programs across the Federal Government. JRAD is a great step forward towards achieving our goal of building the next great middle-market support contractor," Tim Reardon, Broadtree Partners Operating Executive.